| BRAT, Kristián, Monika BRATOVÁ, Jana SKŘIČKOVÁ, Magda BAŘINOVÁ, Karolína HURDÁLKOVÁ, Miloš PEŠEK, Martin SVATOŇ, Libor HAVEL, Markéta ČERNOVSKÁ, Leona KOUBKOVÁ, Michal HRNČIARIK, Jana KREJČÍ, Juraj KULTAN, Ondřej FISCHER, Milada ZEMANOVÁ, Helena ČOUPKOVÁ, Tana TUZOVÁ, Daniel DOLEŽAL a Martin ŠAFANDA. Real-life effectiveness of first-line treatments in NSCLC patients stage IIIB/IV - data from the Czech TULUNG Registry. In European Respiratory Journal 2020, 56: 1683. 2020. Dostupné z: https://dx.doi.org/10.1183/13993003.congress-2020.1683. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1706263,
author = {Brat, Kristián and Bratová, Monika and Skřičková, Jana and Bařinová, Magda and Hurdálková, Karolína and Pešek, Miloš and Svatoň, Martin and Havel, Libor and Černovská, Markéta and Koubková, Leona and Hrnčiarik, Michal and Krejčí, Jana and Kultan, Juraj and Fischer, Ondřej and Zemanová, Milada and Čoupková, Helena and Tuzová, Tana and Doležal, Daniel and Šafanda, Martin},
booktitle = {European Respiratory Journal 2020, 56: 1683},
doi = {http://dx.doi.org/10.1183/13993003.congress-2020.1683},
title = {Real-life effectiveness of first-line treatments in NSCLC patients stage IIIB/IV - data from the Czech TULUNG Registry},
year = {2020}
}
TY - CONF
ID - 1706263
AU - Brat, Kristián - Bratová, Monika - Skřičková, Jana - Bařinová, Magda - Hurdálková, Karolína - Pešek, Miloš - Svatoň, Martin - Havel, Libor - Černovská, Markéta - Koubková, Leona - Hrnčiarik, Michal - Krejčí, Jana - Kultan, Juraj - Fischer, Ondřej - Zemanová, Milada - Čoupková, Helena - Tuzová, Tana - Doležal, Daniel - Šafanda, Martin
PY - 2020
TI - Real-life effectiveness of first-line treatments in NSCLC patients stage IIIB/IV - data from the Czech TULUNG Registry
ER -
BRAT, Kristián, Monika BRATOVÁ, Jana SKŘIČKOVÁ, Magda BAŘINOVÁ, Karolína HURDÁLKOVÁ, Miloš PEŠEK, Martin SVATOŇ, Libor HAVEL, Markéta ČERNOVSKÁ, Leona KOUBKOVÁ, Michal HRNČIARIK, Jana KREJČÍ, Juraj KULTAN, Ondřej FISCHER, Milada ZEMANOVÁ, Helena ČOUPKOVÁ, Tana TUZOVÁ, Daniel DOLEŽAL a Martin ŠAFANDA. Real-life effectiveness of first-line treatments in NSCLC patients stage IIIB/IV - data from the Czech TULUNG Registry. In \textit{European Respiratory Journal 2020, 56: 1683}. 2020. Dostupné z: https://dx.doi.org/10.1183/13993003.congress-2020.1683.
|
